Antihypertensive peptides from milk proteins

Pharmaceuticals

Volumn 3, Issue 1, 2010, Pages 251-272

  Jäkälä, Pauliina ^a   Vapaatalo, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bioactive peptides; Casein; Hypertension; Ile Pro Pro; Lactotripeptides

Indexed keywords

ALPHA LACTORPHIN; ALPHAS1 CASEIN F(143-149); ALPHAS1 CASEIN F(90-94); ALPHAS2 CASEIN F(89-95); ANTIHYPERTENSIVE AGENT; BETA CASEIN F(133-138); BETA LACTORPHIN; BETA LACTOSIN B; CAPTOPRIL; CARDIOVASCULAR AGENT; CASEIN; CASEIN HYDROLYSATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ISOLEUCYLPROLYLPROLINE; LEUCYLPROLYLPROLINE; MILK PROTEIN; PEPTIDE; POTASSIUM; PROTEOME; UNCLASSIFIED DRUG; VALYLPROLYLPROLINE;

AMNION FLUID; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; COUGHING; DIET SUPPLEMENTATION; DIGESTION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; FERMENTATION; FETUS DISEASE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; IC 50; KIDNEY DISEASE; MAXIMUM PLASMA CONCENTRATION; MILK; MINERAL INTAKE; NONHUMAN; PROTEIN HYDROLYSIS; PROTEIN INTAKE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; WHEY;

EID: 77951939683     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3010251     Document Type: Review

References (117)

1. Kearney, P.M.; Whelton, M.; Reynolds, K.; Muntner, P.; Whelton, P.K.; He, J. Global burden of hypertension. Lancet 2005, 365, 217-223.
2. Collins, R.; MacMahon, S. Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease. Br. Med. Bull. 1994, 50, 272-298.
3. Krousel-Wood, M.A.; Muntner, P.; He, J.; Whelton, P.K. Primary prevention of essential hypertension. Med. Clin. North. Am. 2004, 88, 223-238.
4. Chobanian, A.V.; Bakris, G.L.; Black, H.R.; Cushman, W.C.; Green, L.A.; Izzo, J.L.; Jones, D.W.; Materson, B.J.; Oparil, S.; Wright J.T.; Roccella, E.J. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289, 2560-2572.
5. USDA National Nutrient database for Standard Reference. http://www.nal.usda.gov/fnic/foodcomp/search/, accessed November 2009.
6. Mansbridge, R.L.; Blake, J.S. Nutritional factors affecting the fatty acid composition of bovine milk. Br. J. Nutr. 1997, 78, 37-47.
7. McCarron, D.A.; Morris, C.D.; Henry, H.J.; Stanton, J.L. Blood pressure and nutrient intake in the United States. Science 1984, 224, 1392-1398.
8. Alonso, A.; Steffen, L.M.; Folsom, A.R. Dairy intake and changes in blood pressure over 9 years: The ARIC study. Eur. J. Clin. Nutr. 2009, 63, 1272-1275.
9. Wang, L.; Manson J.E.; Buring, J.E.; Lee, I.M.; Sesso, H.D. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 2008, 51, 1073-1079.
10. Toledo, E.; Delgado-Rodríguez, M.; Estruch, R.; Salas-Salvadó, J.; Corella, D.; Gomez-Gracia, E.; Fiol, M.; Lamuela-Raventós, R.M.; Schröder, H.; Arós, F.; Ros, E.; Ruíz-Gutiérrez, V.; Lapetra, J.; Conde-Herrera, M.; Sáez, G.; Vinyoles, E.; Martínez-González, MA. Low-fat dairy products and blood pressure: Follow-up of 2290 older persons at high cardiovascular risk participating the PREDIMED study. Br. J. Nutr. 2009, 101, 59-67.
11. Pereira, M.A.; Jacobs, D.R.; Van Horn, L.; Slattery, M.L.; Kartashov, A.I.; Ludwig, D.S. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: The CARDIA study. JAMA 2002, 287, 2081-2089.
12. Appel, L.J.; Moore, T.J.; Obarzanek, E.; Vollmer, W.M.; Svetkey, L.P.; Sacks, F.M.; Bray, G.A.; Vogt, T.M.; Cutler, J.A.; Windhauser, M.M.; Lin, P.H.; Karanja, N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 1997, 336, 1117-1124.
13. van Beresteijn, E.C.; van Schaik, M.; Schaafsma, G. Milk: Does it affect blood pressure? A controlled intervention study. J. Intern. Med. 1990, 228, 477-482.
14. Buonopane, G.J.; Kilara, A.; Smith, J.S.; McCarthy, R.D. Effect of skim milk supplementation on blood cholesterol concentration, blood pressure, and triglycerides in a free-living human population. J. Am. Coll. Nutr. 1992, 11, 56-67.
15. Hilary Green, J.; Richards, J.K.; Bunning, R.L. Blood pressure responses to high-calcium skim milk and potassium-enriched high-calcium skim milk. J. Hypertens. 2000, 18, 1331-1339.
16. Whelton, P.K.; He, J.; Cutler, J.A. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997, 277, 1624-1632.
17. Geleijnse, J.M.; Kok, F.J.; Grobbee, D.E. Blood pressure response to changes in sodium and potassium intake: A metaregression analysis of randomized trials. J. Hum. Hypertens. 2003, 17, 471-480.
18. van Mierlo, L.A.; Arends, L.R.; Streppel, M.T.; Zeegers, M.P.; Kok, F.J.; Grobbee, D.E.; Geleijnse, J.M. Blood pressure response to calcium supplementation: A meta-analysis of randomized controlled trials. J. Hum. Hypertens. 2006, 20, 571-580.
19. Obarzanek, E.; Velletri, P.A.; Cutler, J.A. Dietary protein and blood pressure. JAMA 1996, 275, 1598-1603.
20. He, J.; Whelton, P.K. Effect of dietary fiber and protein intake on blood pressure: A review of epidemiological evidence. Clin. Exp. Hypertens. 1999, 21, 785-796.
21. Elliot, P.; Stamler, J.; Dyer, A.R.; Appel, L.; Dennis, B.; Kesteloot, H.; Ueshima, H.; Okayama, A.; Chan, Q.; Garside, D.B.; Zhou, B. Association between protein intake and blood pressure. The INTERMAP Study. Arch. Intern. Med. 2006, 166, 79-87.
22. Wang, Y.F.; Yancy, W.S.; Yu, D.; Champagne, C.; Appel, L.J.; Lin, P.H. The relationship between dietary protein intake and blood pressure: Results from the PREMIER study. J. Hum. Hypertens. 2008, 22, 745-754.
23. Burke, V.; Hodgson, J.M.; Beilin, L.J.; Giangiulioi, N.; Rogers, P.; Puddey, I.B. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension 2001, 38, 821-826.
24. Appel, L.J., Sacks, F.M.; Carey, V.J.; Obarzanek, E.; Swain, J.F.; Miller, E.R.; Conlin, P.R.; Erlinger, T.P.; Rosner, B.A.; Laranjo, N.M.; Charleston, J.; McCarron, P.; Bishop, L.M.; OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial. JAMA 2005, 294, 2455-2464.
25. He, J.; Gu, D.; Wu, X.; Chen, J.; Duan, X.; Chen, J.; Whelton, P.K. Effect of soybean protein on blood pressure: A randomized, controlled trial. Ann. Intern. Med. 2005, 143, 1-9.
26. Haug, A.; Hostmark, A.T.; Harstad, O.M. Bovine milk in human nutrition - a review. Lipids Health. Dis. 2007, 6, 25.
27. Pal, S.; Ellis, V. The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity 2009, doi:10.1038/oby.2009.397.
28. Phelan, M.; Aisling, A.; FitzGerald, R.J.; O'Brien, N.M. Casein-derived bioactive peptides: Biological effects, industrial uses, safety aspects and regulatory status. Int. Dairy J. 2009, 19, 643-654.
29. Gill, I.; López-Fandiño, R.; Jorba, X.; Vulfson, E.N. Biologically active peptides and enzymatic approaches to their production. Enzyme. Microb. Technol. 1996, 18, 163-183.
30. Chabance, B.; Marteau, P.; Rambaud, J.C.; Migliore-Samour, D.; Boynard, M.; Perrotin, P.; Guillet, R.; Jollès, P.; Fiat, A.M. Casein peptide release and passage to the blood in humans during digestion of milk and yoghurt. Biochimie 1998, 80, 155-165.
31. Parrot, S.; Degraeve, P.; Curia, C.; Martial-Gros, A. In vitro study on digestion of peptides in Emmental cheese: Analytical evaluation and influence on angiotensin I converting enzyme inhibitory peptides. Nahrung 2003, 47, 87-94.
32. Hernández-Ledesma, B.; Amigo, L.; Ramos, M.; Recio, I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. J. Agric. Food Chem. 2004, 52, 1504-1510.
33. Shimizu, M. Food-derived peptides and intestinal functions. BioFactors 2004, 21, 43-47.
34. Christensen, J.E.; Dudley, E.G.; Pederson, J.A.; Steele, J.L. Peptidases and amino acid catabolism in lactic acid bacteria. Antonie van Leeuwenhoek 1999, 76, 2117-2146.
35. Juillard, V.; Guillot, A.; Le Bars, D.; Gripon, J.C. Specificity of milk peptide utilization by Lactococcus lactis. Appl. Environ. Microbiol. 1998, 64, 1230-1236.
36. Nakamura, Y.; Yamamoto, N.; Sakai, K.; Okubo, A.; Yamazaki, S.; Takano, T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 1995, 78, 777-783.
37. Nakamura, Y.; Yamamoto, N.; Sakai, K.; Takano, T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 1995, 78, 1253-1257.
38. FitzGerald, R.J.; Murray, B.A. Bioactive peptides and lactic fermentations. Int. J. Dairy Technol. 2006, 59, 118-125.
39. Pihlanto-Leppälä, A.; Koskinen, P.; Piilola, K.; Tupasela, T.; Korhonen, H. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. J. Dairy Res. 2000, 67, 53-64.
40. Wu, J.; Ding, X. Characterization of inhibition and stability of soy-protein derived angiotensin I-converting enzyme inhibitory peptides. Food Res. Int. 2002, 35, 367-375.
41. Minervini, F.; Algaron, F.; Rizzello, C.G.; Fox, P.F.; Monnet, V.; Gobbetti, M. Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl. Environ. Microbiol. 2003, 69, 5297-5305.
42. Korhonen, H.; Pihlanto, A. Food-derived bioactive peptides - Opportunities for designing future foods. Curr. Pharm. Des. 2003, 9, 1297-1308.
43. Korhonen, H.J. Milk-derived bioactive peptides: From science to applications. J. Functional Foods 2009, 1, 177-187.
44. Meyer, J.; Bütikofer, U.; Walther, B.; Wechsler, D.; Sieber, R. Hot topic: Changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties. J. Dairy Sci. 2009, 92, 826-836.
45. Yamamoto, N.; Maeno, M., Takano, T. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 1999, 82, 1388-1393.
46. Yamamoto, N.; Akino, A.; Takano, T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 1994, 77, 917-922.
47. Lehtinen, R.; Jauhiainen, T.; Kankuri, E.; Lindstedt, K.; Kovanen, P.T.; Kerojoki, O.; Korpela, R.; Vapaatalo, H. Effects of milk casein-derived tripeptides Ile-Pro-Pro, Val-Pro-Pro, and Leu-Pro-Pro on enzymes processing vasoactive precursors in vitro. Arzneim. Forsch/Drug Res. 2010, in press.
48. Yamamoto, N.; Akino, A.; Takano, T. Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci. Biotech. Biochem. 1994, 58, 776-778.
49. Nakamura, Y.; Masuda, O.; Takano, T. Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci. Biotech. Biochem. 1996, 60, 488-489.
50. Sipola, M.; Finckenberg, P.; Santisteban, J.; Korpela, R.; Vapaatalo, H.; Nurminen, M.L. Longterm intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J. Physiol. Pharmacol. 2001, 52, 745-754.
51. Sipola, M.; Finckenberg, P.; Korpela, R.; Vapaatalo, H; Nurminen, M.L. Effect of long-term intake of milk products on blood pressure in hypertensive rats. J. Dairy Res. 2002, 69, 103-111.
52. Jauhiainen, T.; Collin, M.; Narva, M.; Cheng, Z.J.; Poussa, T.; Vapaatalo, H; Korpela, R. Effect of long-term intake of milk peptides and minerals on blood pressure and arterial function in spontaneously hypertensive rats. Milchwissenschaft 2005, 60, 358-362.
53. Jäkälä, P.; Pere, E; Lehtinen, R.; Turpeinen, A.; Korpela, R.; Vapaatalo, H. Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats. J. Physiol. Pharmacol. 2009, 60, 11-20.
54. Jäkälä, P.; Hakala, A.; Turpeinen, A.; Korpela, R.; Vapaatalo, H. Casein-derived bioactive tripeptides Ile-Pro-Pro and Val-Pro-Pro attenuate the development of hypertension and improve endothelial function in salt-loaded Goto-Kakizaki rats. J. Functional Foods 2009, 1, 366-374.
55. Jauhiainen, T.; Pilvi, T.; Cheng, Z.J.; Kautiainen, H.; Müller, D.N.; Vapaatalo, H., Korpela, R.; Mervaala, E. Milk products containing bioactive tripeptides have an antihypertensive effect in double transgenic rats (dTGR) harbouring human renin and human angiotensinogen genes. J. Nutr. Metab. 2010, doi:10.1155/2010/287030.
56. Masuda, O.; Nakamura, Y.; Takano, T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 1996, 126, 3063-3068.
57. Jäkälä, P.; Jauhiainen, T.; Korpela, R.; Vapaatalo, H. Milk protein-derived bioactive tripeptides Ile-Pro-Pro and Val-Pro-Pro protect endothelial function in vitro in hypertensive rats. J. Functional Foods 2009, 1, 266-273.
58. del Mar Contreras, M.; Carrón, R.; Montero, M.J.; Ramos, M.; Recio, I. Novel casein-derived peptides with antihypertensive activity. Int. Dairy J. 2009, 19, 566-573.
59. Quirós, A.; Ramos, M.; Muguerza, B.; Delgado, M.A.; Miguel, M.; Aleixandre, A.; Recio, I. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. Int. Dairy J. 2007, 17, 33-41.
60. Antila, P.; Paakkari, I.; Järvinen, A.; Mattila, M.J.; Laukkanen, M.; Pihlanto-Leppälä, A.; Mäntsälä, P.; Hellman, J. Opioid peptides derived from in-vitro proteolysis of bovine whey proteins. Int. Dairy J. 1991, 1, 215-229.
61. Nurminen, M.L.; Sipola, M.; Kaarto, H.; Pihlanto-Leppälä, A.; Piilola, K.; Korpela, R.; Tossavainen, O.; Korhonen, H.; Vapaatalo, H. α-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci. 2000, 66, 1535-1543.
62. Sipola, M.; Finckenberg, P.; Vapaatalo, H.; Pihlanto-Leppälä, A.; Korhonen, H.; Korpela, R.; Nurminen, M-L. Alpha-lactorphin and beta-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci. 2002, 71, 1245-1253.
63. Murakami, M.; Tonouchi, H.; Takahashi, R.; Kitazawa, H.; Kawai, Y.; Negishi, H.; Saito, T. Structural analysis of a new anti-hypertensive peptide (beta-lactosin B) isolated from a commercial whey product. J. Dairy Sci. 2004, 87, 1967-1974.
64. Abubakar, A.; Saito, T.; Kitazawa, H.; Kawai, Y.; Itoh, T. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J. Dairy Sci. 1998, 81, 3131-3138.
65. Marshall, K. Therapeutic applications of whey protein. Altern. Med. Rev. 2004, 9, 136-156.
66. Saito, T. Antihypertensive peptides derived from bovine casein and whey proteins. Adv. Exp. Med. Biol. 2008, 606, 295-317.
67. Pripp, A.H. Effect of peptides derived from food proteins on blood pressure: A meta-analysis of randomized controlled trials. Food Nutr. Res. 2008, 52, doi: 10.3402/fnr.v52i0.1641.
68. Xu, J.Y.; Qin, L.Q.; Wang, P.Y.; Li, W.; Chang, C. Effect of milk tripeptides on blood pressure: A meta-analysis of randomized controlled trials. Nutrition 2008, 24, 933-940.
69. Engberink, M.F.; Schouten, E.G.; Kok, F.J.; van Mierlo, L.A.J.; Brouwer, I.A.; Geleijnse, J.M. Lactotripeptides show no effect on human blood pressure. Results from a double-blind randomized controlled trial. Hypertension 2008, 51, 399-405.
70. van der Zander, K.; Bots, M.L.; Bak, A.A.A.; Koning, M.M.G.; de Leeuw, P.W. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. Am. J. Clin. Nutr. 2008, 88, 1697-1702.
71. van der Zander, K.; Jakel, M.; Bianco, V.; Koning, M.M. Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. J. Hum. Hypertens. 2008, 22, 804-806.
72. de Leeuw, P.W.; van der Zander, K.; Kroon, A.A.; Rennenberg, R.M.; Koning, M.M. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Press. 2009, 18, 44-50.
73. Nakamura, T.; Mizutani, J.; Sasaki, K.; Yamamoto, N.; Takazawa, K. Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: A preliminary study. J. Med. Food 2009, doi:10.1089/jmf.2009.0159.
74. Yoshizawa, M.; Maeda, S.; Miyaki, A.; Misono, M.; Choi, Y.; Shimojo, N.; Ajisaka, R.; Tanaka, H. Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women. Am. J. Physiol. Heart. Circ. Physiol. 2009, 297, 1899-1902.
75. Turpeinen, A.M.; Kumpu, M.; Rönnback, M.; Seppo, L.; Kautiainen, H.; Jauhiainen, T.; Vapaatalo, H.; Korpela, R. Antihypertensive and cholesterol-lowering effects of a spread containing bioactive peptides IPP and VPP and plant sterols. J. Functional Foods 2009, 1, 260-265.
76. van Mierlo, L.A.J.; Koning, M.M.G.; van der Zander, K.; Draijer, R. Lactotripeptides do not lower blood pressure in untreated whites: Results from 2 controlled multicenter crossover studies. Am. J. Clin. Nutr. 2009, 89, 617-623.
77. Kajimoto, O.; Aihara, K.; Hirata, H.; Takahashi, R.; Nakamura, Y. Hypotensive effects of tablets containing "lactotripeptides (VPP, IPP)". J. Nutr. Food 2001, 4, 51-61.
78. Seppo, L.; Kerojoki, O.; Suomalainen, T.; Korpela, R. The effect of a Lactobacillus helveticus LBK-16H fermented milk on hypertension - a pilot study on humans. Milchwissenschaft 2002, 57, 124-127.
79. Nakamura, Y.; Kajimoto, O.; Kaneko, K.; Aihara, K.; Mizutani, J.; Ikeda, N.; Nishimura, A.; Kajimoto, Y. Effects of the liquid yogurts containing "lactotripeptide (VPP, IPP)" on highnormal blood pressure. J. Nutr. Food 2004, 7, 123-137.
80. Aihara, K.; Kajimoto, O.; Hirata, H.; Takahashi, R.; Nakamura, Y. Effect of powdered milk fermented with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J. Am. Coll. Nutr. 2005, 24, 257-265.
81. Mizuno, S.; Matsuura, K.; Gotou, T.; Nishimura, S.; Kajimoto, O.; Yabune, M.; Kajimoto, Y.; Yamamoto, N. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br. J. Nutr. 2005, 94, 84-91.
82. Hirota, T.; Ohki, K.; Kawagishi, R.; Kajimoto, Y.; Mizuno, S.; Nakamura, Y.; Kitakaze, M. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: Contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens. Res. 2007, 30, 489-496.
83. Sano, J.; Ohki, K.; Higuchi, T.; Aihara, K.; Mizuno, S.; Kajimoto, O.; Nakagawa, A.; Kajimoto, Y.; Nakamura, Y. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J. Med. Food 2005, 8, 423-430.
84. Jauhiainen, T.; Vapaatalo, H.; Poussa, T.; Kyrönpalo, S.; Rasmussen, M.; Korpela, R. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am. J. Hypertens. 2005, 18, 1600-1605.
85. Boelsma, E.; Kloek, J. Lactotripeptides and antihypertensive effects: A critical review. Br. J. Nutr. 2009, 101, 776-786.
86. Pins, J.J.; Keenan, J.M. Effects of whey peptides on cardiovascular disease risk factors. J. Clin. Hypertens. (Greenwich), 2006, 8, 775-782.
87. Lee, Y.M.; Skurk, T.; Hennig, M.; Hauner, H. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur. J. Nutr. 2007, 46, 21-27.
88. Miguel, M.; Dávalos, A.; Manso, M.A.; de la Peña, G.; Lasunción, M.A.; López-Fandiño, R. Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-Ile. Mol. Nutr. Food Res. 2008, 12, 1507-1513.
89. Foltz, M.; Cerstiaens, A.; van Meensel, A.; Mols, R.; van der Pijl, P.C.; Duchateau, G.S.M.J.E, Augustijns, P. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. Peptides 2008, 29, 1312-1320.
90. Foltz, M.; Meynen, E.E.; Bianco, V.; van Platerink, C.; Koning, T.M.M.G.; Kloek, J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J. Nutr. 2007, 137, 953-958.
91. van der Pijl, P.C.; Kies, A.K.; Ten Have, G.A.M.; Duchateau, G.S.M.J.E.; Deutz, N.E.P. Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 2008, 29, 2196-2202.
92. Vanhoof, G.; Goossens, F.; De Meester, I.; Hendriks, D.; Scharpé, S. Proline motifs in peptides and their biological processing. FASEB J. 1995, 9, 736-744.
93. Jauhiainen, T.; Wuolle, K.; Vapaatalo, H.; Kerojoki, O.; Nurmela, K.; Lowrie, C.; Korpela, R. Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats. Int. Dairy J. 2007, 17, 1216-1223.
94. Dolan, E.; Thijs, L.; Li, Y.; Atkins, N.; McCormack, P.; McClory, S.; O'Brien, E.; Staessen, J.A.; Stanton, A.V. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006, 47, 365-370.
95. Chirinos, J.A.; Zambrano, J.P.; Chakko, S.; Veerani, A.; Schob, A.; Willens, H.J.; Perez, G.; Mendez, A.J. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005, 45, 980-985.
96. Jauhiainen, T.; Rönnback, M.; Vapaatalo, H.; Wuolle, K.; Kautiainen, H.; Korpela, R. Lactobacillus helveticus fermented milk reduces arterial stiffness in hypertensive subjects. Int. Dairy J. 2007, 17, 1209-1211.
97. Jauhiainen, T. Blood pressure lowering effects of Lactobacillus helveticus fermented milk containing bioactive peptides Ile-Pro-Pro and Val-Pro-Pro: Mechanistic, Kinetic and Clinical Studies. Doctoral dissertation. University of Helsinki, Faculty of Medicine, Institute of Biomedicine. Helsinki 2007.
98. Yamaguchi, N.; Kawaguchi, K.; Yamamoto, N. Study of the mechanism of antihypertensive peptide VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. Eur. J. Pharmacol. 2009, 620, 71-77.
99. De Gennaro, C.V.; Rossoni, G.; Rigamonti, A.; Bonomo, S.; Manfredi, B.; Berti, F.; Muller, E. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur. J. Pharmacol. 2002, 450, 61-66.
100. Rummery, N.M.; Grayson, T.H.; Hill, C.E. Angiotensin-converting enzyme inhibition restores endothelial but not medial connexin expression in hypertensive rats. J. Hypertens. 2005, 23, 317-328.
101. Fyhrquist, F.; Saijonmaa, O. Renin-angiotensin system revisited. J. Intern. Med. 2008, 264, 224-236.
102. Wei, L.; Clauser, E.; Alhenc-Gelas, F.; Corvol, P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 1992, 267, 13398-13405.
103. Natesh, R.; Schwager, S.L.U.; Sturrock, E.D.; Acharya, K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003, 421, 551-554.
104. Meisel, H. Biochemical properties of peptides encrypted in bovine milk proteins. Curr. Med. Chem. 2005, 12, 1905-1919.
105. Wuerzner, G.; Peyrard, S.; Blanchard, A.; Lalanne, F.; Azizi, M. The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans. J. Hypertens. 2009, 27, 1404-1409.
106. Pripp, A.H.; Isaksson, T.; Stepaniak, L.; Sørhaug, T. Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. Eur. Food Res. Technol. 2004, 219, 579-583.
107. Wu, J.; Aluko, R.E.; Nakai, S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of di- and tripeptides. J. Agric. Food Chem. 2006, 54, 732-738.
108. Foltz, M.; van Buren, L.; Klaffke, W.; Duchateau, GSMJE. Modeling of the relationship between dipeptide structure and dipeptide stability, permeability, and ACE-inhibitory activity. J. Food Sci. 2009, 74, 243-251.
109. FDA GRAS Substances (SCOGS) Database 2006. http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASSubstancesSCOGSDatabase/default.htm/, accessed 30 December 2009.
110. Commission regulation (EC) No 983/2009. OJEU, 2009, L277:3-L277:8.
111. Piepho, R.W. Overview of the angiotensin-converting-enzyme inhibitors. Am. J. Health Syst. Pharm. 2000, 57, 3-7.
112. Pryde, P.G.; Sedman, A.B.; Nugent, C.E.; Barr, M. Angiotensin-converting enzyme inhibitor fetopathy. J. Am. Soc. Nephrol. 1993, 3, 1575-1582.
113. Quan, A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum. Dev. 2006, 82, 23-28.
114. Maeno, M.; Nakamura, Y.; Mennear, J.H.; Bernard, B.K. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): III. Single- and/or repeated-dose toxicity of tripeptides-containing Lactobacillus helveticus-fermented milk powder and casein hydrolysate in rats. Int. J. Toxicol. 2005, 24, 13-23.
115. Dent, M.P.; O'Hagan, S.; Braun, W.H.; Schaetti, P.; Marburger, A.; Vogel, O. A 90-day subchronic toxicity study and reproductive toxicity studies on ACE-inhibiting lactotripeptide. Food Chem. Toxicol. 2007, 45, 1468-1477.
116. Ponstein-Simarro Doorten, A.Y.; vd Wiel, J.A.G.; Jonker, D. Safety evaluation of an IPP tripeptide-containing milk protein hydrolysate. Food Chem. Toxicol. 2009, 47, 55-61.
117. Corrigendum to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims on foods. OJEU 2007, L12:3-L12:18. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:012:00 03:0018:EN:PDF/, accessed 19 January 2010.